Eva McLellan

Eva McLellan is a Global Biotech Executive with over 18 years of experience, currently driving innovation in Cardiovascular, Renal, and Metabolism (CVRM) at Roche as Vice President and General Manager. Previously, they held various roles at Roche, including International Business Leader and Disease Area Director, where they spearheaded global strategies and successful product launches in oncology and rare conditions. Eva has also contributed to academic circles as a guest lecturer at the University of Toronto and serves on the board of several organizations, including AmCham Slovenia and the World Economic Forum. They earned a Master’s degree in Biotechnology & Genetics from the University of Toronto and have pursued executive education at prestigious institutions like INSEAD and The Wharton School.